79 results on '"off-label"'
Search Results
2. Paediatric Drug Development in Japan: Current Status and Future Challenges
3. Antipsychotic prescribing: national findings of children and adolescents attending mental health services in Ireland
4. In-label, off-label prescription, efficacy and tolerability of dalbavancin: report from a National Registry
5. Off-label use of medicines in South Africa: a review
6. Rapid deployment aortic valve implantation in complex patients with infective endocarditis or aortic valve insufficiency
7. Trends and off-label utilization of antipsychotics in children and adolescents from 2016 to 2021 in China: a real-world study
8. Adverse drug reactions in paediatric surgery: prospective study on frequency and risk related factors
9. Off-label prescription: developing a guideline and validating an instrument to measure physicians’ and clinical pharmacists’ knowledge and attitudes toward off-label medication use
10. COVID-19 and MIS-C treatment in children—results from an international survey
11. Off-label use of immune checkpoint inhibitors for the treatment of solid tumors: analysis of a nationwide patient sample
12. The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world
13. Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case
14. Intravenous ketamine for severe alcohol use disorder at Moi Teaching & Referral Hospital, Kenya: a case report
15. Trends of Expanding Indications of Woven EndoBridge Devices for the Treatment of Intracranial Aneurysms: A Systematic Review and Meta-analysis
16. Novel and Off-Label Biologic Use in the Management of Hidradenitis Suppurativa, Pyoderma Gangrenosum, Lichen Planus, and Seborrheic Dermatitis: A Narrative Review
17. Off-label use of antidepressants, antipsychotics, and mood-stabilizers in psychiatry
18. Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review
19. Systematic Data Monitoring and Analysis of Cardiovascular Off-label Prescriptions in Pediatrics: Focus on Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Beta Blockers
20. Off–label long acting injectable antipsychotics in real–world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Network DEPOT study
21. Lumen-apposing metal stents for approved and off-label indications: a single-centre experience
22. Denosumab for the treatment of primary pediatric osteoporosis
23. Kindermedika.at
24. Safe and pivotal approaches using contrast-enhanced ultrasound for the diagnostic workup of non-obstetric conditions during pregnancy, a single-center experience
25. Are We Jumping the Gun with Itolizumab in India? A Situational Analysis from the Pre-COVID Era
26. Off-label use of antipsychotic medications in psychiatric inpatients in China: a national real-world survey
27. Off-label use of bevacizumab for wet age-related macular degeneration in Europe
28. Real-world assessment of off-label direct oral anticoagulant dosing for venous thromboembolism
29. Omalizumab as a last resort therapy for intractable, severe chronic allergic rhinosinusitis
30. Safety of intrathecal route: focus to methylprednisolone acetate (Depo-Medrol) use
31. Two decades of off-label prescribing in children: a literature review
32. Towards preventive pharmacovigilance through medicine misuse identification: an example with recombinant human growth hormone for aesthetic purposes
33. Pattern and extent of off-label and unlicensed drug use in neonatal intensive care units in Iran
34. IL-1-Blockade mit Anakinra in der Schwangerschaft: Retrospektive Wirksamkeits- und Sicherheitsanalyse bei Patientinnen mit familiärem Mittelmeerfieber
35. Off-label-Biologikatherapie von ANCA-assoziierten und nicht-ANCA-assoziierten Kleingefäßvaskulitiden: Wirksamkeits- und Sicherheitsanalyse eines nationalen Registers (GRAID2)
36. Off-label-Biologikatherapie bei Patienten mit Großgefäßvaskulitiden und/oder Polymyalgia rheumatica: Wirksamkeits- und Sicherheitsanalyse eines nationalen Registers (GRAID2)
37. Nivolumab for recurrent cutaneous squamous cell carcinoma: three cases
38. Comparison of mid-term clinical outcomes between on-label and off-label use of rotational atherectomy
39. Recombinant activated factor VII (rFVIIa) in refractory haemorrhage for non-haemophiliacs: an eleven-year single-centre experience
40. Reasons for exclusion from intravenous thrombolysis in stroke patients admitted to the Stroke Unit
41. Can Registration Procedures of Pharmaceuticals Inadvertently Contribute to Off-Label Prescribing in Children?
42. Antihistamines prescribed off-label among paediatric patients at a tertiary care hospital setting in Malaysia
43. Hyaluronsäure in der Brustchirurgie
44. Memantin bei Optikusatrophie in Friedreich-Ataxie
45. Incident users of antipsychotics: who are they and how do they fare?
46. Assessment of off-label use of denosumab 60 mg injection during the early postmarketing period using health insurance claims data
47. Off-Label Uses of Omalizumab
48. Off-label prescribing of psychotropic drugs in a Danish child and adolescent psychiatric outpatient clinic
49. Using price–volume agreements to manage pharmaceutical leakage and off-label promotion
50. x?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.